Amine functionalised hydroxyapatite nanoparticles for anti-angiogenesis gene therapy of breast cancer

被引:10
作者
Xu, Hongjie [1 ]
Wei, Dajun [2 ]
Gai, Xiaodong [3 ]
Jiang, Ying [4 ]
机构
[1] Beihua Univ, Dept Oncol, Affiliated Hosp, 12 Jiefang Middle Rd, Jilin 132011, Jilin Province, Peoples R China
[2] Beihua Univ, Dept Cardiol, Affiliated Hosp, 12 Jiefang Middle Rd, Jilin 132011, Jilin Province, Peoples R China
[3] Beihua Univ, Sch Basic Med Sci, 3999 Binjiang East Rd, Jilin 132011, Jilin Province, Peoples R China
[4] Hlth Serv Ctr Wenmiao Community, Jilin 132011, Jilin Province, Peoples R China
来源
MICRO & NANO LETTERS | 2016年 / 11卷 / 08期
关键词
nanoparticles; nanomedicine; cancer; sodium compounds; gene therapy; cellular biophysics; drug delivery systems; amine functionalised hydroxyapatite nanoparticles; antiangiogenesis gene therapy; functionalised hydroxyapatite nanoparticle-based drug delivery system; antiangiogenesis-amine functionalised HAP nanoparticles; therapeutic ANG plasmid; plasmid condensation; cellular assays; MCF-7; cells; ANG-NHAP nanoparticle low-cytotoxicity; breast cancer gene therapy; Ca-10(PO4)(6)(OH)(2); ENDOTHELIAL GROWTH-FACTOR; TARGETED CO-DELIVERY; IN-VITRO; CELLS; DRUG; POLYETHYLENEIMINE; EXPRESSION; RECEPTOR; VIVO;
D O I
10.1049/mnl.2016.0078
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
A functionalised hydroxyapatite (HAP) nanoparticles based drug delivery system (DDS) [anti-angiogenesis (ANG)/amine functionalised HAP (NHAP) nanoparticles] composed of HAP nanoparticles and therapeutic ANG plasmid was successfully developed for gene therapy of breast cancer. ANG/NHAP nanoparticles displayed nano-sized diameter of around 50 nm and effective plasmid condensation ability. Cellular assays on MCF-7 cells further confirmed high transfection and ANG efficacy as well as low cytotoxicity of ANG/NHAP nanoparticles, which suggested that ANG/NHAP nanoparticles might be a safe and effective DDS for potential breast cancer gene therapy.
引用
收藏
页码:416 / 419
页数:4
相关论文
共 18 条
  • [1] Amaya K, 2004, INT J ONCOL, V25, P849
  • [2] Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling
    Anandanadesan, Rathai
    Gong, Qiaoke
    Chipitsyna, Galina
    Witkiewicz, Agnes
    Yeo, Charles J.
    Arafat, Hwyda A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (01) : 57 - 66
  • [3] A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy
    Bao, Xiuli
    Wang, Wei
    Wang, Cheng
    Wang, Yu
    Zhou, Jianping
    Ding, Yang
    Wang, Xiaoyi
    Jin, Yuting
    [J]. BIOMATERIALS, 2014, 35 (29) : 8450 - 8466
  • [4] Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102
  • [5] Chen QR, 1999, CANCER RES, V59, P3308
  • [6] ANTI-ANGIOGENESIS - NEW CONCEPT FOR THERAPY OF SOLID TUMORS
    FOLKMAN, J
    [J]. ANNALS OF SURGERY, 1972, 175 (03) : 409 - &
  • [7] Candesartan-graft-polyethyleneimine Cationic Micelles for Effective Co-delivery of Drug and Gene in Anti-angiogenic Lung Cancer Therapy
    Hao, Shanhu
    Yan, Ying
    Ren, Xue
    Xu, Ying
    Chen, Lanlan
    Zhang, Haibo
    [J]. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2015, 20 (03) : 550 - 560
  • [8] The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy
    Hou, Chun-Han
    Hou, Sheng-Mou
    Hsueh, Yu-Sheng
    Lin, Jinn
    Wu, Hsi-Chin
    Lin, Feng-Huei
    [J]. BIOMATERIALS, 2009, 30 (23-24) : 3956 - 3960
  • [9] Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration
    Laurencin, CT
    Attawia, MA
    Lu, LQ
    Borden, MD
    Lu, HH
    Gorum, WJ
    Lieberman, JR
    [J]. BIOMATERIALS, 2001, 22 (11) : 1271 - 1277
  • [10] Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver
    Morimoto, K
    Nishikawa, M
    Kawakami, S
    Nakano, T
    Hattori, Y
    Fumoto, S
    Yamashita, F
    Hashida, M
    [J]. MOLECULAR THERAPY, 2003, 7 (02) : 254 - 261